Fractional CO2 laser for the treatment of Peyronie’s disease
With encouraging results at 52 weeks, fractional CO<sub>2</sub> laser therapy may serve as a well-tolerated and minimally invasive therapy for PD in the future.
Authors
- Abdullah Alhamam
- Ryan Flannigan (ORCID: https://orcid.org/0000-0001-6964-7521)
- Luke Witherspoon (ORCID: https://orcid.org/0000-0002-2174-264X)
- Jason K. Rivers (ORCID: https://orcid.org/0000-0002-0131-1607)
- Justin Y.H. Chan (ORCID: https://orcid.org/0000-0001-7952-9123)
Institutions
- University of British Columbia (CA)
- University of Toronto (CA)
- Ottawa Hospital (CA)
- SKiN Health (CA)
- Imam Abdulrahman Bin Faisal University (SA)
Publication Details
- Journal
- Canadian Urological Association Journal
- Published
- 2024-10-07
- DOI
- https://doi.org/10.5489/cuaj.8852
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00